Details:

Alternative Title:
Hepatology
Publisher's site:
http://dx.doi.org/10.1002/hep.27736
Personal Author:
Leidner, Andrew J. ; Chesson, Harrell W. ; Xu, Fujie ; Ward, John W. ; Spradling, Philip R. ; ... More +
Leidner, Andrew J. ; Chesson, Harrell W. ; Xu, Fujie ; Ward, John W. ; Spradling, Philip R. ; Holmberg, Scott D. Less -
Description:
Conclusion

Immediate treatment of HCV-infected patients with moderate and advanced fibrosis appears to be cost-effective, and immediate treatment of patients with minimal or no fibrosis can be cost-effective as well, particularly when lower treatment costs are assumed.


Subject:
[+]
Antiviral Agents
Article
Cost-Benefit Analysis
Hepatitis C
Humans
Models, Economic

Source:
Hepatology. 61(6):1860-1869.
Pubmed ID:
25677072
Pubmed Central ID:
PMC5802336
Document Type:
Journal Article
Funding:
CC999999/Intramural CDC HHS/United States
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:37edca4ce02dcaa459792ea8bc203e2c4c4ae3fcfeeacd8c5637f075995ecb5c
File Type:

Supporting Files

• 	NIHMS938924-supplement-Appendix.pdf	pdf
  	nihms938924.nxml	xml
  	nihms938924f1.gif	gif
  	nihms938924f1.jpg	jpeg
  	nihms938924f2.gif	gif
  	nihms938924f2.jpg	jpeg

More +